Floatz logo

Medroxyprogesterone acetate

GnRH Antagonist

ShangHai Ji Ai Genetics & IVF InstitutePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the GnRH Antagonist cohort.

Asset / SponsorPhaseRating
TEVERELIX
Antev Ltd.
Phase 2CCC
Teverelix Dp
Antev Ltd.
Phase 2CCC

Same molecule, other indications

Medroxyprogesterone acetate is also rated in:

osteoporosisDormant
BBB
Indicative ·
72 / 100
View asset →
cardiovascular disorderDormant
BB
Indicative ·
65 / 100
View asset →
sickle cell diseaseDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →